Skip to main content
Search
Search
Anywhere
Quick Search anywhere
Enter words / phrases / DOI / ISBN / keywords / authors / etc
Search
Advanced Search
Login
Skip main navigation
Open Drawer Menu
Close Drawer Menu
Home
Journal of Comparative Effectiveness Research
Journal of Patient Centricity
The Evidence Base
Skip slideshow
Journal of Comparative Effectiveness Research
ISSN (print): 2042-6305 • ISSN (online): 2042-6313
Impact Factor: 2.8 (2025) • CiteScore: 4.2 (2025) • Open Access
Read more
Journal of Patient Centricity
ISSN (online): 2978-8579
In partnership with the PCSIG • Open Access
Read more
The Evidence Base
Latest news, opinion and insight into hot topics including RWE, HEOR, HTA and market access
Read more
Latest
Treatment gaps in osteoporosis care following recurrent fractures: a nationwide cohort study
Hyun Jin Han
,
Miryoung Kim
,
Eyoung Wang
,
Min Ji Kim
, and
Hae Sun Suh
Journal of Comparative Effectiveness Research
3 Aug 2026
Effect of dose tapering policy on the prescription of advanced therapy for rheumatoid arthritis: a retrospective analysis of clinical and cost outcomes in Taiwan
Ko-Jen Li
,
Chao-Hsiun Tang
,
Chia-Li Chang
,
Han-Fang Liao
,
Pei-Jung Yen
, and
Wen-Yi Shau
Journal of Comparative Effectiveness Research
30 Jul 2026
UK's Innovative Licensing and Access Pathway awards Innovation Passports to two investigational liver cancer and dementia medicines
The Evidence Base
4 Aug 2026
Industry update tracker: July 2026
The Evidence Base
4 Aug 2026
Journal of Comparative Effectiveness Research
Open access, peer-reviewed journal offering rapid publication for all aspects of HEOR and related areas
Read More
FROM THE EVIDENCE BASE
4 Aug 2026
Industry update tracker: July 2026
4 Aug 2026
WEBINAR: Can HEOR prove its own value? A discussion with the ROI of HEOR Working Group representatives – October 8, 2026
3 Aug 2026
John Snow Labs and 3Aware partner to support secure real-world evidence generation
4 Aug 2026
UK's Innovative Licensing and Access Pathway awards Innovation Passports to two investigational liver cancer and dementia medicines
4 Aug 2026
Industry update tracker: July 2026
28 Jul 2026
Another JCA initiated as daraxonrasib enters EU HTA process alongside EMA phased review
4 Aug 2026
WEBINAR: Can HEOR prove its own value? A discussion with the ROI of HEOR Working Group representatives – October 8, 2026
3 Aug 2026
Editor’s highlights from the
Journal of Comparative Effectiveness Research
– August 2026
15 Jul 2026
Following the patient journey: How connected data and evolving methods are reshaping real-world evidence
The Evidence Base
Online hub providing the latest news, opinion and insights into HEOR, RWE, HTA and more
Read More
FROM THE EVIDENCE BASE
4 Aug 2026
UK's Innovative Licensing and Access Pathway awards Innovation Passports to two investigational liver cancer and dementia medicines
4 Aug 2026
Industry update tracker: July 2026
4 Aug 2026
WEBINAR: Can HEOR prove its own value? A discussion with the ROI of HEOR Working Group representatives – October 8, 2026
3 Aug 2026
John Snow Labs and 3Aware partner to support secure real-world evidence generation
.png)
.png)
